Cases & Deals

Ventac invests in multimmune

Clients Ventac Partners GmbH

Jones Day counseled Ventac Partners GmbH in connection with its purchase of Common Stock in a private placement by multimmune GmbH, a private biopharmaceutical company focused on the development of innovative therapeutic approaches for the treatment of cancers.